Sepsis-3: Insights from the Lead Author

Type de salle

Permanent

Prénom

Ce champ est obligatoire.

Nom

Ce champ est obligatoire.

Adresse e-mail

Ce champ est obligatoire.

Société

Ce champ est obligatoire.

Champs obligatoires

Paiement par

Avant d'acheter votre billet, veuillez consulter ici la configuration technique permettant d’assister à l’événement.

Si vous êtes déjà inscrit et ne trouvez pas votre e-mail de confirmation d'inscription, cliquez ici !

Test de configuration système. Cliquez ici !

Marvyn Singer, MD

Mervyn Singer, MB BS, MD, FRCP (Lon), FRCP (Edin), FFICM, is Professor of Intensive Care Medicine and Director of the Bloomsbury Institute of Intensive Care Medicine at University College London, UK, since 2001. He was Senior Investigator at the National Institute of Health Research from 2009 to 2017 and is currently the Sepsis Topic Advisor for NICE. Dr Singer was Co-chair of the Sepsis-3 Consensus Task Force and lead author of "The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3).

Ordre du jour des événements

This special session features Dr. Mervyn Singer, lead author of Sepsis-3 guidelines and co-author of the new update to SOFA, SOFA-2.

In this session, Dr. Singer:

Outlines why the Sepsis-2 SIRS criteria are now regarded as outdated and inadequate.
Describes the development process of the Sepsis-3 guidelines.
Discusses the latest revisions to the SOFA score, known as SOFA-2.
Debunks the common sepsis denial rationales presented by payers.

Recording is available for 90 days after purchase.